Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Withdrawn 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Lymphoma, B-Cell 1

Interventions

pembrolizumab 2reducing agent and tunicamycin-responsive protein, human 1olutasidenib 1epacadostat 1ebselen 1dexamethasone acetate 1dexamethasone 21-phosphate 1decitabine and cedazuridine drug combination 1daratumumab 1carfilzomib 1auricularum 1Vorinostat 1Surveys and Questionnaires 1Specimen Handling 1Magnetic Resonance Spectroscopy 1Kidney Transplantation 1Immunotherapy, Adoptive 1Immunoglobulin G 1Hyaluronoglucosaminidase 1Fluorodeoxyglucose F18 1Electrochemotherapy 1Dexamethasone 1Continuous Positive Airway Pressure 1Cell- and Tissue-Based Therapy 1Calcium Dobesilate 1Bleomycin 1Biopsy 1A-dmDT390-bisFv(UCHT1) protein 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Cell- and Tissue-Based Therapy × 30 days × Clear all
NCT05312476 2026-06-03

Clinical Study on CAR-T Targeting Igβ Targets in Refractory Relapsed Non-Hodgkin's Lymphoma

The First Affiliated Hospital of Soochow University

Phase 2 Withdrawn
Lymphoid

Lymphoma, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡